Attainment of goal and normalized lipid levels with lipid-modifying therapy in Malaysia

Hsu TY 1 , Chirovsky D , Moy FM , Ambegaonkar BM

Affiliations 

  • 1 Merck Sharp & Dohme (I.A.) Corp., Singapore Branch, Singapore
Clin Ther, 2013 Apr;35(4):450-60.
PMID: 23481458 DOI: 10.1016/j.clinthera.2013.02.004

Abstract

Although LDL-C is the primary lipid target for coronary heart disease (CHD) risk reduction, HDL-C and triglycerides (TG) have also emerged as CHD risk factors.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

MeSH terms
Similar publications